SEARCH:   Advanced

Receive this page by email each issue: [Sign up for eTOCs] Other Issues: April 16 2009; 113 (16)   [Index by Author]  [Cover Caption]  [Complete Inside Blood PDF]         INSIDE BLOOD        REVIEW ARTICLES        CLINICAL TRIALS AND OBSERVATIONS        GENE THERAPY        HEMATOPOIESIS AND STEM CELLS        IMMUNOBIOLOGY        LYMPHOID NEOPLASIA        MYELOID NEOPLASIA        PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS        PLATELETS AND THROMBOPOIESIS        RED CELLS, IRON, AND ERYTHROPOIESIS        THROMBOSIS AND HEMOSTASIS        TRANSPLANTATION        CORRESPONDENCE Find articles in this issue containing these words: [Search ALL Issues] Table of Contents (PDF) | Editorial Board (PDF) | Front Matter (PDF) | Back Matter (PDF) | Advertising (PDF) To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link. INSIDE BLOOD: FVIIa gene delivery: potential treatment for hemophilia? John H. McVey Blood 2009 113: 3649-3650. [Full Text] [PDF]   Truth or dare: role of Liar in EPO-dependent signaling Dwayne L. Barber Blood 2009 113: 3650-3651. [Full Text] [PDF]   MiR-sensing chemotherapy resistance in CLL George A. Calin Blood 2009 113: 3652-3653. [Full Text] [PDF]   REVIEW ARTICLES: Differentiation therapy of leukemia: 3 decades of development Daniel Nowak, Daphne Stewart, and H. Phillip Koeffler Blood 2009 113: 3655-3665. Prepublished online February 12, 2009; DOI 10.1182/blood-2009-01-198911 [Abstract] [Full Text] [PDF]   CLINICAL TRIALS AND OBSERVATIONS: Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005 Åsa Rangert Derolf, Sigurdur Yngvi Kristinsson, Therese M.-L. Andersson, Ola Landgren, Paul W. Dickman, and Magnus Björkholm Blood 2009 113: 3666-3672. Prepublished online November 19, 2008; DOI 10.1182/blood-2008-09-179341 [Abstract] [Full Text] [PDF]   Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia Steven P. Treon, Andrew R. Branagan, Leukothea Ioakimidis, Jacob D. Soumerai, Christopher J. Patterson, Barry Turnbull, Parveen Wasi, Christos Emmanouilides, Stanley R. Frankel, Andrew Lister, Pierre Morel, Jeffrey Matous, Stephanie A. Gregory, and Eva Kimby Blood 2009 113: 3673-3678. Prepublished online November 17, 2008; DOI 10.1182/blood-2008-09-177329 [Abstract] [Full Text] [PDF]   Brief report  Malignant mesothelioma after radiation treatment for Hodgkin lymphoma Marie L. De Bruin, Jacobus A. Burgers, Paul Baas, Mars B. van 't Veer, Evert M. Noordijk, Marieke W. J. Louwman, Josée M. Zijlstra, Hendrik van den Berg, Berthe M. P. Aleman, and Flora E. van Leeuwen Blood 2009 113: 3679-3681. Prepublished online February 20, 2009; DOI 10.1182/blood-2008-10-184705 [Abstract] [Full Text] [PDF]   GENE THERAPY: Successful treatment of canine hemophilia by continuous expression of canine FVIIa Paris Margaritis, Elise Roy, Majed N. Aljamali, Harre D. Downey, Urs Giger, Shangzhen Zhou, Elizabeth Merricks, Aaron Dillow, Mirella Ezban, Timothy C. Nichols, and Katherine A. High Blood 2009 113: 3682-3689. Prepublished online December 23, 2008; DOI 10.1182/blood-2008-07-168377 [Abstract] [Full Text] [PDF]   HEMATOPOIESIS AND STEM CELLS: Forward RNAi screens in primary human hematopoietic stem/progenitor cells Nicole Ali, Christine Karlsson, Marie Aspling, Guang Hu, Nir Hacohen, David T. Scadden, and Jonas Larsson Blood 2009 113: 3690-3695. Prepublished online February 2, 2009; DOI 10.1182/blood-2008-10-176396 [Abstract] [Full Text] [PDF] [Supplemental Figure]   IMMUNOBIOLOGY: T-cell receptor– and CD28-induced Vav1 activity is required for the accumulation of primed T cells into antigenic tissue Rachel David, Liang Ma, Aleksandar Ivetic, Aya Takesono, Anne J. Ridley, Jian-Guo Chai, Victor L. Tybulewicz, and Federica M. Marelli-Berg Blood 2009 113: 3696-3705. Prepublished online December 5, 2008; DOI 10.1182/blood-2008-09-176511 [Abstract] [Full Text] [PDF] [Supplemental Figures]   Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting Nancy S. Longo, Patricia L. Lugar, Sule Yavuz, Wen Zhang, Peter H. L. Krijger, Daniel E. Russ, Dereje D. Jima, Sandeep S. Dave, Amrie C. Grammer, and Peter E. Lipsky Blood 2009 113: 3706-3715. Prepublished online November 20, 2008; DOI 10.1182/blood-2008-10-183632 [Abstract] [Full Text] [PDF] [Supplemental Tables and Figures]   Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses Pierre Bruhns, Bruno Iannascoli, Patrick England, David A. Mancardi, Nadine Fernandez, Sylvie Jorieux, and Marc Daëron Blood 2009 113: 3716-3725. Prepublished online November 18, 2008; DOI 10.1182/blood-2008-09-179754 [Abstract] [Full Text] [PDF] [Supplemental Table and Figures]   In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein Risaku Fukumoto, Vibeke Andresen, Izabela Bialuk, Valentina Cecchinato, Jean-Claude Walser, Valerio W. Valeri, Julie M. Nauroth, Antoine Gessain, Christophe Nicot, and Genoveffa Franchini Blood 2009 113: 3726-3734. Prepublished online September 12, 2008; DOI 10.1182/blood-2008-04-146928 [Abstract] [Full Text] [PDF]   LYMPHOID NEOPLASIA: The impact of Fc engineering on an anti-CD19 antibody: increased Fc receptor affinity enhances B-cell clearing in nonhuman primates Jonathan Zalevsky, Irene W. L. Leung, Sher Karki, Seung Y. Chu, Eugene A. Zhukovsky, John R. Desjarlais, David F. Carmichael, and Chris E. Lawrence Blood 2009 113: 3735-3743. Prepublished online December 24, 2008; DOI 10.1182/blood-2008-10-182048 [Abstract] [Full Text] [PDF]   Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation Deepa Sampath, George A. Calin, Vinay K. Puduvalli, Gopal Gopisetty, Cristian Taccioli, Chang-Gong Liu, Brett Ewald, Chaomei Liu, Michael J. Keating, and William Plunkett Blood 2009 113: 3744-3753. Prepublished online December 18, 2008; DOI 10.1182/blood-2008-09-178707 [Abstract] [Full Text] [PDF] [Supplemental Methods, Table, and Figures]   Differentiation stage–specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas Raquel Malumbres, Kristopher A. Sarosiek, Elena Cubedo, Jose W. Ruiz, Xiaoyu Jiang, Randy D. Gascoyne, Robert Tibshirani, and Izidore S. Lossos Blood 2009 113: 3754-3764. Prepublished online December 1, 2008; DOI 10.1182/blood-2008-10-184077 [Abstract] [Full Text] [PDF] [Supplemental Methods, Tables, and Figures]   Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20 David Daydé, David Ternant, Marc Ohresser, Stéphanie Lerondel, Sabrina Pesnel, Hervé Watier, Alain Le Pape, Pierre Bardos, Gilles Paintaud, and Guillaume Cartron Blood 2009 113: 3765-3772. Prepublished online November 24, 2008; DOI 10.1182/blood-2008-08-175125 [Abstract] [Full Text] [PDF]   Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival Nathalie A. Johnson, Merrill Boyle, Ali Bashashati, Stephen Leach, Angela Brooks-Wilson, Laurie H. Sehn, Mukesh Chhanabhai, Ryan R. Brinkman, Joseph M. Connors, Andrew P. Weng, and Randy D. Gascoyne Blood 2009 113: 3773-3780. Prepublished online November 24, 2008; DOI 10.1182/blood-2008-09-177469 [Abstract] [Full Text] [PDF] [Supplemental Figure]   Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks Enrique M. Ocio, Patricia Maiso, Xi Chen, Mercedes Garayoa, Stela Álvarez-Fernández, Laura San-Segundo, David Vilanova, Lucía López-Corral, Juan C. Montero, Teresa Hernández-Iglesias, Enrique de Álava, Carlos Galmarini, Pablo Avilés, Carmen Cuevas, Jesús F. San-Miguel, and Atanasio Pandiella Blood 2009 113: 3781-3791. Prepublished online November 19, 2008; DOI 10.1182/blood-2008-09-177774 [Abstract] [Full Text] [PDF] [Supplemental Tables]   A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity John E. Weldon, Laiman Xiang, Oleg Chertov, Inger Margulies, Robert J. Kreitman, David J. FitzGerald, and Ira Pastan Blood 2009 113: 3792-3800. Prepublished online November 6, 2008; DOI 10.1182/blood-2008-08-173195 [Abstract] [Full Text] [PDF]   miR-34a as part of the resistance network in chronic lymphocytic leukemia Thorsten Zenz, Julia Mohr, Eric Eldering, Arnon P. Kater, Andreas Bühler, Dirk Kienle, Dirk Winkler, Jan Dürig, Marinus H. J. van Oers, Daniel Mertens, Hartmut Döhner, and Stephan Stilgenbauer Blood 2009 113: 3801-3808. Prepublished online October 21, 2008; DOI 10.1182/blood-2008-08-172254 [Abstract] [Full Text] [PDF] [Supplemental Table]   Brief report  Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab Shannon P. Hilchey, Ollivier Hyrien, Tim R. Mosmann, Alexandra M. Livingstone, Jonathan W. Friedberg, Faith Young, Richard I. Fisher, Raymond J. Kelleher, Jr, Richard B. Bankert, and Steven H. Bernstein Blood 2009 113: 3809-3812. Prepublished online February 4, 2009; DOI 10.1182/blood-2008-10-185280 [Abstract] [Full Text] [PDF]   MYELOID NEOPLASIA: ICSBP-mediated immune protection against BCR-ABL–induced leukemia requires the CCL6 and CCL9 chemokines Valentina Nardi, Olaia Naveiras, Mohammad Azam, and George Q. Daley Blood 2009 113: 3813-3820. Prepublished online January 26, 2009; DOI 10.1182/blood-2008-07-167189 [Abstract] [Full Text] [PDF] [Supplemental Table and Figures]   PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS: Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation Masafumi Nakayama, Hisaya Akiba, Kazuyoshi Takeda, Yuko Kojima, Masaaki Hashiguchi, Miyuki Azuma, Hideo Yagita, and Ko Okumura Blood 2009 113: 3821-3830. Prepublished online February 17, 2009; DOI 10.1182/blood-2008-10-185884 [Abstract] [Full Text] [PDF] [Supplemental Methods and Figures]   PLATELETS AND THROMBOPOIESIS: A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function Nicole Soranzo, Augusto Rendon, Christian Gieger, Chris I. Jones, Nicholas A. Watkins, Stephan Menzel, Angela Döring, Jonathan Stephens, Holger Prokisch, Wendy Erber, Simon C. Potter, Sarah L. Bray, Philippa Burns, Jennifer Jolley, Mario Falchi, Brigitte Kühnel, Jeanette Erdmann, Heribert Schunkert, Nilesh J. Samani, Thomas Illig, Stephen F. Garner, Angela Rankin, Christa Meisinger, John R. Bradley, Swee Lay Thein, Alison H. Goodall, Tim D. Spector, Panos Deloukas, and Willem H. Ouwehand Blood 2009 113: 3831-3837. Prepublished online February 12, 2009; DOI 10.1182/blood-2008-10-184234 [Abstract] [Full Text] [PDF] [Supplemental Tables]   T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a–specific, HLA-DRB3*0101–restricted CD4+ T cells Maria Therese Ahlen, Anne Husebekk, Mette Kjær Killie, Bjørn Skogen, and Tor B. Stuge Blood 2009 113: 3838-3844. Prepublished online January 9, 2009; DOI 10.1182/blood-2008-09-178475 [Abstract] [Full Text] [PDF]   RED CELLS, IRON, AND ERYTHROPOIESIS: Liar, a novel Lyn-binding nuclear/cytoplasmic shuttling protein that influences erythropoietin-induced differentiation Amy L. Samuels, S. Peter Klinken, and Evan Ingley Blood 2009 113: 3845-3856. Prepublished online December 8, 2008; DOI 10.1182/blood-2008-04-153452 [Abstract] [Full Text] [PDF] [Supplemental Tables, Figures, and Video]   THROMBOSIS AND HEMOSTASIS: Unique secretion mode of human protein Z: its Gla domain is responsible for inefficient, vitamin K–dependent and warfarin-sensitive secretion Masayoshi Souri, Hiroki Iwata, Wei Guang Zhang, and Akitada Ichinose Blood 2009 113: 3857-3864. Prepublished online February 2, 2009; DOI 10.1182/blood-2008-07-171884 [Abstract] [Full Text] [PDF] [Supplemental Figures]   TRANSPLANTATION: Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease Stefanie Sarantopoulos, Kristen E. Stevenson, Haesook T. Kim, Corey S. Cutler, Nazmim S. Bhuiya, Michael Schowalter, Vincent T. Ho, Edwin P. Alyea, John Koreth, Bruce R. Blazar, Robert J. Soiffer, Joseph H. Antin, and Jerome Ritz Blood 2009 113: 3865-3874. Prepublished online January 23, 2009; DOI 10.1182/blood-2008-09-177840 [Abstract] [Full Text] [PDF]   Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell–depleted allogeneic hematopoietic cell transplantation Junli Yu, Jeffrey M. Venstrom, Xiao-Rong Liu, James Pring, Reenat S. Hasan, Richard J. O'Reilly, and Katharine C. Hsu Blood 2009 113: 3875-3884. Prepublished online January 28, 2009; DOI 10.1182/blood-2008-09-177055 [Abstract] [Full Text] [PDF] [Supplemental Figures]   CORRESPONDENCE: Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease Alexander Röth, Andreas Hüttmann, Russell P. Rother, Ulrich Dührsen, and Thomas Philipp Blood 2009 113: 3885-3886. [Full Text] [PDF]   Homozygous deletion of HFE: the Sardinian hemochromatosis? Sara Pelucchi, Raffaella Mariani, Francesca Bertola, Cristina Arosio, and Alberto Piperno Blood 2009 113: 3886. [Full Text] [PDF]   To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020